Konturek Peter, Konturek Kathrin, Zopf Yurdagül, Harsch Igor A
Klinik für Innere Medizin II, Thüringen-Kliniken Saalfeld, Deutschland.
Chefarzt der Klinik für Innere Medizin II, Thüringen-Kliniken "Georgius Agricola" GmbH, Standort Saalfeld, Rainweg 68, 07318, Saalfeld, Deutschland.
MMW Fortschr Med. 2020 Mar;162(Suppl 4):9-14. doi: 10.1007/s15006-020-0228-y. Epub 2020 Mar 19.
The intestinal microbiota must be seen as an elementary component of our health.
Review article RESULTS AND CONCLUSIONS: An abnormal gut microbiota (dysbiosis) plays an essential role in the pathogenesis of functional and inflammatory bowel diseases. It is often also associated with diseases outside the intestine. The exact causality remains unclear ("chicken and egg problem"). With the help of prebiotics, probiotics or fecal microbiota therapy, relevant therapeutic effects can be achieved in chronic, dysbiosis-associated diseases. The choice of the preparation depends on the clinical symptoms, the duration of the treatment depends on the particular clinical picture.
肠道微生物群必须被视为我们健康的一个基本组成部分。
综述文章
异常的肠道微生物群(生态失调)在功能性和炎症性肠病的发病机制中起重要作用。它通常也与肠道外疾病有关。确切的因果关系仍不清楚(“鸡生蛋还是蛋生鸡”问题)。借助益生元、益生菌或粪便微生物群疗法,在慢性、与生态失调相关的疾病中可取得相关治疗效果。制剂的选择取决于临床症状,治疗持续时间取决于具体临床表现。